Olfactory Training for Post-COVID-19 Olfactory Dysfunction: A Meta-Analysis of Efficacy and Combination Therapies.

J Clin Med · 2025 · PMC12470729 · PMID 41010778

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

borderline significantp = 0.05actually significant

While the use of corticosteroids showed a borderline significant benefit (MD = 1.34, 95% CI: 0.01–2.67, p = 0.05), ALA supplementation did not significantly enhance olfactory recovery (MD = 0.50, 95% CI: −0.07–1.07, p = 0.08).

also in 5,455 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.